Respiratory Weekly News - June 27th 2025
Respiratory & Pulmonary Health Updates: Gaps in Asthma Care, PAH…
Respiratory Weekly News - May 23rd 2025
Lung & Respiratory Breakthroughs: IPF Therapies, Asthma Innovations, COPD…
ATS 2025 Preview: Key Respiratory Highlights To Watch
ATS 2025 at a glance Prepare for ATS 2025 with LucidQuest’s concise preview,…
Respiratory Weekly News - May 9th 2025
Lung & Respiratory Health Breakthroughs: Nucala COPD Data, Breztri Asthma…
Respiratory Weekly News - May 2nd 2025
Lung & Respiratory Health Updates: CF Drug Approvals, RSV Breakthroughs,…
Respiratory Weekly News - 25th April 2025
Lung & Respiratory Breakthroughs: Trelegy Data, EGPA Drug Status,…
AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…
How our strategic intelligence helped a respiratory brand, understand the future landscape and adapt its clinical development program (CDP).
The Challenge: Staying updated with the ever-changing competitive landscape in…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches.
The challenge: How to prepare when two new competitors enter your space Α…
A major pharma in the COPD / Asthma space strengthened its market position due to competitive intelligence obtained through conference coverage.
The Challenge: Gathering competitive intelligence at conferences Α major…
How we helped a specialty respiratory company understand the "trends" of severe asthma and COPD assets and position itself strategically.
The Challenge: Staying updated with emerging trends in the respiratory market…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches
The Challenge: How to prepare when two new competitors enter your space Α…